Physician profile
Jay D Ryan
NPI 1649573205
$7,602.66
in general payments reported to CMS, 2019-2025
49 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,252 · 2020: $951 · 2021: $1,187 · 2022: $1,158 · 2023: $887 · 2024: $1,268 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,054.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,668.37 | 2019-2025 | Iconix, Regenkit-Tht, Prostep Mica |
| Ani Pharmaceuticals, INC. | $963.03 | 2024-2025 | Purified Cortrophin Gel, Oxistat, Sovuna |
| Paratek Pharmaceuticals, INC. | $592.82 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $564.72 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $502.16 | 2019-2025 | Collagenase Santyl, Regranex, Pico 7 |
| Convatec INC. | $365.61 | 2023-2025 | |
| Integra Lifesciences Corporation | $316.89 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $226.37 | 2019-2022 | |
| Supreme Orthopedic Systems, LLC | $224.28 | 2023-2025 | |
| Orthofix Medical, INC. | $174.36 | 2020-2024 | Accelstim, Physio-Stim |
| Sandoz INC. | $173.18 | 2019-2020 | |
| Ossio INC | $152.47 | 2021-2023 | |
| Bioventus LLC | $146.60 | 2019-2022 | |
| Depuy Synthes Sales INC. | $117.97 | 2019-2025 | Healix Knotless Peek, Dynacord |
| Wright Medical Technology, INC. | $104.29 | 2019-2020 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $88.74 | 2019-2021 | |
| Kerecis Limited | $84.44 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Checkpoint Surgical, INC | $77.12 | 2023-2025 | Checkpoint Stimulators |
| Biocomposites INC | $72.45 | 2019 | |
| Amgen INC. | $71.63 | 2024-2025 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $63.72 | 2020-2023 | Jublia |
| Trice Medical, INC. | $63.08 | 2022 | |
| Organogenesis INC. | $58.04 | 2020-2023 | Puraply |
| Sebela Pharmaceuticals INC. | $55.05 | 2019-2022 | |
| Nevro Corp. | $54.75 | 2022-2024 | Senza |
| Abbvie INC. | $50.27 | 2021-2022 | |
| Medtronic, INC. | $48.94 | 2022-2024 | Intellis Adaptivestim |
| Hikma Pharmaceuticals USA | $46.67 | 2020-2022 | |
| Acera Surgical, INC. | $43.29 | 2024 | Restrata Wound Matrix |
| Arthrosurface Incorporated | $36.57 | 2019 | |
| Tactile Systems Technology INC | $35.10 | 2019 | |
| Glenmark Therapeutics INC. | $33.00 | 2019 | |
| Abbott Laboratories | $31.03 | 2021 | |
| Linvatec Corporation | $26.47 | 2019-2025 | Neospan, Colink Afx, Biobrace 23mm |
| Lifenet Health | $25.44 | 2025 | Theragenesis Wound Matrix |
| Arteriocyte Medical Systems, INC. | $23.13 | 2023 | Magellan |
| Triad Life Sciences INC. | $22.85 | 2022 | |
| Merck Sharp & Dohme LLC | $22.78 | 2019 | |
| Fidia Pharma USA INC. | $21.82 | 2019 | |
| Polynovo North America LLC | $21.30 | 2024 | Novosorb Btm |
| Misonix INC | $17.96 | 2019 | |
| Davol INC. | $17.29 | 2020 | |
| Progenacare Global, LLC | $16.25 | 2024 | |
| Avanos Medical | $15.37 | 2022 | |
| Osteomed LLC | $14.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.80 | 2022 | |
| Osiris Therapeutics INC. | $12.53 | 2019 | |
| Paragon 28, INC. | $12.35 | 2022 | |
| Pfizer INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.